tiprankstipranks
Trending News
More News >
Sight Sciences (SGHT)
NASDAQ:SGHT
US Market
Advertisement

Sight Sciences (SGHT) Earnings Dates, Call Summary & Reports

Compare
91 Followers

Earnings Data

Report Date
Mar 05, 2026
After Close (Confirmed)
Period Ending
2025 (Q4)
Consensus EPS Forecast
-0.16
Last Year’s EPS
-0.23
Same Quarter Last Year
Moderate Buy
Based on 7 Analysts Ratings

Earnings Call Summary

Q3 2025
Earnings Call Date:Nov 06, 2025|
% Change Since:
|
Earnings Call Sentiment|Neutral
The earnings call reflects a mixed sentiment with several positive developments such as increased revenue guidance, successful payer coverage for TearCare, and growth in Surgical Glaucoma revenue. However, these are balanced by challenges including a decline in overall revenue and Dry Eye segment revenue, impact of tariff costs, and the reported net loss.
Company Guidance
In the recent earnings call, Sight Sciences provided updated guidance for the fiscal year 2025, reflecting strong performance and strategic advancements. The company raised its full-year revenue guidance to a range of $76 million to $78 million, driven by the successful adoption of its OMNI Surgical Glaucoma technology, which contributed significantly to the third quarter revenue of $19.9 million. Additionally, Sight Sciences lowered its adjusted operating expense guidance for the year, aiming for a reduction of 9% to 11% compared to 2024, highlighting improved expense management and operational efficiency. The call also emphasized the strategic importance of recent Medicare pricing schedules established for the TearCare system by First Coast Service Options and Novitas Solutions, which are expected to expand market opportunities for reimbursed interventional dry eye procedures. The company anticipates these developments, coupled with momentum in its Surgical Glaucoma segment, to drive sustained long-term growth.
Increased Revenue Guidance
Sight Sciences raised its full-year 2025 revenue guidance to $76 million to $78 million, up from the previous guidance of $72 million to $76 million.
Surgical Glaucoma Revenue Growth
The Surgical Glaucoma segment reported a revenue of $19.7 million in Q3 2025, reflecting a 6% increase compared to the same period in the previous year.
Successful Payer Coverage for TearCare
The company achieved pricing schedules for TearCare with First Coast Service Options and Novitas Solutions, covering 10.4 million Medicare lives and setting a payment rate of approximately $1,142.
Record High for Ordering Accounts
Ordering accounts reached a record high for the second consecutive quarter, with a 2% sequential increase and an 8% increase compared to the previous year.
Management Restructuring
Promotion of Ali Bauerlein to Chief Operating Officer and Jim Rodberg to Chief Financial Officer, both having significant experience within the company.

Sight Sciences (SGHT) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

SGHT Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Mar 05, 2026
2025 (Q4)
-0.16 / -
-0.23
Nov 06, 2025
2025 (Q3)
-0.25 / -0.16
-0.2227.27% (+0.06)
Aug 07, 2025
2025 (Q2)
-0.26 / -0.23
-0.258.00% (+0.02)
May 08, 2025
2025 (Q1)
-0.28 / -0.28
-0.3315.15% (+0.05)
Mar 05, 2025
2024 (Q4)
-0.20 / -0.23
-0.22-4.55% (-0.01)
Nov 07, 2024
2024 (Q3)
-0.21 / -0.22
-0.2718.52% (+0.05)
Aug 01, 2024
2024 (Q2)
-0.30 / -0.25
-0.316.67% (+0.05)
May 02, 2024
2024 (Q1)
-0.28 / -0.33
-0.355.71% (+0.02)
Mar 07, 2024
2023 (Q4)
-0.32 / -0.22
-0.3537.14% (+0.13)
Nov 07, 2023
2023 (Q3)
-0.32 / -0.27
-0.4641.30% (+0.19)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

SGHT Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 06, 2025
$5.00$5.82+16.40%
Aug 07, 2025
$3.55$4.24+19.44%
May 08, 2025
$3.03$3.08+1.65%
Mar 05, 2025
$2.42$2.49+2.89%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Sight Sciences (SGHT) report earnings?
Sight Sciences (SGHT) is schdueled to report earning on Mar 05, 2026, After Close (Confirmed).
    What is Sight Sciences (SGHT) earnings time?
    Sight Sciences (SGHT) earnings time is at Mar 05, 2026, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is SGHT EPS forecast?
          SGHT EPS forecast for the fiscal quarter 2025 (Q4) is -0.16.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis